Cargando…
The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
BACKGROUND: Immunosenescence, the age-related decline of immunity, affects the immune responses of melanoma patients. Through immune responses, immune checkpoint inhibitors (ICIs) exert their antitumor robustness. In different ages of melanoma patients, especially the older patients, the effectivene...
Autores principales: | Li, Ping, Yang, Xuefang, Feng, Yumiao, Wu, Lijuan, Ma, Wei, Ding, Gaozhong, Wei, Yun, Sun, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208870/ https://www.ncbi.nlm.nih.gov/pubmed/30464500 http://dx.doi.org/10.2147/OTT.S165368 |
Ejemplares similares
-
Efficacy of immune checkpoint inhibitors for in-transit melanoma
por: Nan Tie, Emilia, et al.
Publicado: (2020) -
Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Publicado: (2020) -
Efficacy of immune checkpoint inhibitors in different types of melanoma
por: Rossi, Ernesto, et al.
Publicado: (2020) -
Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018) -
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
por: van Akkooi, Alexander C. J., et al.
Publicado: (2022)